Literature DB >> 17440786

Voxel-based NK1 receptor occupancy measurements with [(18)F]SPA-RQ and positron emission tomography: a procedure for assessing errors from image reconstruction and physiological modeling.

Esa Wallius1, Mikko Nyman, Vesa Oikonen, Jarmo Hietala, Ulla Ruotsalainen.   

Abstract

PURPOSE: Receptor occupancy studies with positron emission tomography (PET) are widely used as aids in the drug development process. This study introduces a general procedure for assessing errors that arise from the applied image processing methods in PET receptor occupancy studies using the neurokinin-1 (NK1) receptor occupancy study as an example. PROCEDURES: The bias and variance among eight combinations of image reconstruction and model calculation methods for estimating voxel-level receptor occupancy results were examined. The tests were performed using a dynamic numerical phantom based on a previous PET drug occupancy study with the NK1 receptor antagonist tracer [(18)F]SPA-RQ.
RESULTS: The simplified reference tissue model with basis functions (SRTM BF) was best at estimating receptor occupancy in terms of average bias. On the other hand, median root prior (MRP) image reconstruction produced the lowest variances in the occupancy estimates. These results suggest that SRTM BF and MRP is, in this case, the combination of choice in voxel-based receptor occupancy calculation. In the calculation of regional binding potential values, the commonly used sample mean is not applicable and, e.g., the median could be used instead.
CONCLUSIONS: This study shows that even this kind of complicated receptor study can be statistically evaluated. The reconstruction methods had an effect on the variance in the voxel-based receptor occupancy calculation. The model calculation methods influenced the average bias. The test method was found useful in assessing the methodological sources of systematic and random error in receptor occupancy estimation with PET.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17440786     DOI: 10.1007/s11307-007-0096-1

Source DB:  PubMed          Journal:  Mol Imaging Biol        ISSN: 1536-1632            Impact factor:   3.484


  36 in total

1.  Statistical image reconstruction methods for randoms-precorrected PET scans.

Authors:  M Yavuz; J A Fessler
Journal:  Med Image Anal       Date:  1998-12       Impact factor: 8.545

2.  Noise reduction in the simplified reference tissue model for neuroreceptor functional imaging.

Authors:  Yanjun Wu; Richard E Carson
Journal:  J Cereb Blood Flow Metab       Date:  2002-12       Impact factor: 6.200

3.  Gender and age affect NK1 receptors in the human brain - a positron emission tomography study with [18F]SPA-RQ.

Authors:  Mikko J Nyman; Olli Eskola; Jaana Kajander; Tero Vahlberg; Sandra Sanabria; Donald Burns; Richard Hargreaves; Olof Solin; Jarmo Hietala
Journal:  Int J Neuropsychopharmacol       Date:  2006-03-30       Impact factor: 5.176

4.  Lack of efficacy of the substance p (neurokinin1 receptor) antagonist aprepitant in the treatment of major depressive disorder.

Authors:  Martin Keller; Stuart Montgomery; William Ball; Mary Morrison; Duane Snavely; Guanghan Liu; Richard Hargreaves; Jarmo Hietala; Christopher Lines; Katherine Beebe; Scott Reines
Journal:  Biol Psychiatry       Date:  2005-10-24       Impact factor: 13.382

5.  Molecular cloning, structural characterization and functional expression of the human substance P receptor.

Authors:  Y Takeda; K B Chou; J Takeda; B S Sachais; J E Krause
Journal:  Biochem Biophys Res Commun       Date:  1991-09-30       Impact factor: 3.575

6.  Deficits in visceral pain and hyperalgesia of mice with a disruption of the tachykinin NK1 receptor gene.

Authors:  J M Laird; T Olivar; C Roza; C De Felipe; S P Hunt; F Cervero
Journal:  Neuroscience       Date:  2000       Impact factor: 3.590

7.  Altered nociception, analgesia and aggression in mice lacking the receptor for substance P.

Authors:  C De Felipe; J F Herrero; J A O'Brien; J A Palmer; C A Doyle; A J Smith; J M Laird; C Belmonte; F Cervero; S P Hunt
Journal:  Nature       Date:  1998-03-26       Impact factor: 49.962

8.  Establishing the dose of the oral NK1 antagonist aprepitant for the prevention of chemotherapy-induced nausea and vomiting.

Authors:  Sant P Chawla; Steven M Grunberg; Richard J Gralla; Paul J Hesketh; Cindy Rittenberg; Mary E Elmer; Carrie Schmidt; Arlene Taylor; Alexandra D Carides; Judith K Evans; Kevin J Horgan
Journal:  Cancer       Date:  2003-05-01       Impact factor: 6.860

9.  Demonstration of the efficacy and safety of a novel substance P (NK1) receptor antagonist in major depression.

Authors:  Mark S Kramer; Andrew Winokur; Jeffrey Kelsey; Sheldon H Preskorn; Anthony J Rothschild; Duane Snavely; Kalyan Ghosh; William A Ball; Scott A Reines; Dennis Munjack; Jeffrey T Apter; Lynn Cunningham; Mitchel Kling; Mohammed Bari; Albert Getson; Yih Lee
Journal:  Neuropsychopharmacology       Date:  2004-02       Impact factor: 7.853

10.  Neurokinin 1 receptor and relative abundance of the short and long isoforms in the human brain.

Authors:  Laura Caberlotto; Yasmin L Hurd; Paul Murdock; Jean Philippe Wahlin; Sergio Melotto; Mauro Corsi; Renzo Carletti
Journal:  Eur J Neurosci       Date:  2003-05       Impact factor: 3.386

View more
  3 in total

1.  Relative equilibrium plot improves graphical analysis and allows bias correction of standardized uptake value ratio in quantitative 11C-PiB PET studies.

Authors:  Yun Zhou; Jitka Sojkova; Susan M Resnick; Dean F Wong
Journal:  J Nucl Med       Date:  2012-03-13       Impact factor: 10.057

2.  Direct 4D parametric imaging for linearized models of reversibly binding PET tracers using generalized AB-EM reconstruction.

Authors:  Arman Rahmim; Yun Zhou; Jing Tang; Lijun Lu; Vesna Sossi; Dean F Wong
Journal:  Phys Med Biol       Date:  2012-01-18       Impact factor: 3.609

3.  A consistent and efficient graphical analysis method to improve the quantification of reversible tracer binding in radioligand receptor dynamic PET studies.

Authors:  Yun Zhou; Weiguo Ye; James R Brasić; Andrew H Crabb; John Hilton; Dean F Wong
Journal:  Neuroimage       Date:  2008-10-01       Impact factor: 6.556

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.